0000950170-24-009803.txt : 20240201 0000950170-24-009803.hdr.sgml : 20240201 20240201161502 ACCESSION NUMBER: 0000950170-24-009803 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240201 DATE AS OF CHANGE: 20240201 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001593899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460574869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39661 FILM NUMBER: 24587105 BUSINESS ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: SUITE 2100 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-204-8109 MAIL ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: SUITE 2100 CITY: BOSTON STATE: MA ZIP: 02110 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Sommadossi Jean-Pierre CENTRAL INDEX KEY: 0001296995 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 125 SUMMER STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 144 1 primary_doc.xml 144 0001296995 XXXXXXXX LIVE 0001593899 Atea Pharmaceuticals, Inc. 001-39661 225 Franklin Street Suite 2100 Boston MA 02110 857-284-8891 Jean-Pierre Sommadossi President, CEO, and Chairman Common Stock Morgan Stanley

2000 Westchester Ave Purchase NY 10577-2530

65476 266487.32 83435513 02/01/2024 NASDAQ Common Stock 01/31/2024 Shares acquired upon vesting of restricted stock units awarded under Issuer's 2020 Incentive Award Plan Issuer N 173467 01/31/2023 Services rendered Y 02/01/2024 05/18/2023 /s/ Jean-Pierre Sommadossi